Johnson & Johnson (JNJ) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は New Brunswick, NJ, アメリカ. 現CEOは Joaquin Duato.
JNJ を有する IPO日 1943-01-02, 138,100 名の正社員, に上場 NYSE, 時価総額 $578.62B.
Johnson & Johnson is a global healthcare company focused on innovative pharmaceuticals and medical devices following its 2023 strategic separation of its consumer health business into Kenvue Inc. The company's Innovative Medicine segment develops prescription medications for complex diseases including rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders. Its MedTech segment provides advanced medical technology solutions spanning electrophysiology, neurovascular care, orthopedic implants, surgical systems, and ACUVUE contact lenses. Operating worldwide and headquartered in New Brunswick, New Jersey, Johnson & Johnson serves hospitals, healthcare professionals, wholesalers, and retailers while maintaining its mission of advancing human health since 1886.
